Ann Arbor Stage II Diffuse Large B-Cell Lymphoma Suspended Phase 1 Trials for Ibrutinib (DB09053)

IndicationStatusPhase
DBCOND0093202 (Ann Arbor Stage II Diffuse Large B-Cell Lymphoma)Suspended1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03220022Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell LymphomasTreatment